Itamar Shalit

Prof. Shalit is an Associate Professor in Pediatrics, Sackler Faculty of Medicine, Tel-Aviv University, and a world authority in Pediatric Infectious Diseases. Prof. Shalit served as the Director of the Infectious Diseases Unit and Director General of Schneider Children`s Hospital, tertiary care, referral pediatric center, for the entire state of Israel. He also served as the Director-General of Carmel Hospital, the Chairman of the Israeli Society for Infectious Diseases, and as a member of the Scientific Advisory Boards of leading pharma and biotech companies including Bioline Rx, Teva Innovative Ventures, NasVax, and Integra Ltd. Prof. Shalit is an active member of several national committees of the Israeli Ministry of Health among them the Advisory Board on Infectious Diseases and Immunization, Polio Eradication Committee, and the Epidemics Management Team. He was awarded the Certificate of Appreciation Declaration by the World Health Organization for outstanding efforts and success in poliomyelitis eradication in Israel. Prof. Shalit holds an MD from the Sackler School of Medicine, Tel-Aviv University, and an MPA (Master in Public Administration) from the Kennedy School of Government at Harvard University. He is the author of more than 90 peer-reviewed scientific papers and currently serves as the CEO of the Galilee Biomedical Research Administration.